Overview
Financials
Revenue history (in m)
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2002-07-01. Active
33 1600 1462 1080 5538 1000 0002
45 1750 0009 0000 0000 2348 6962
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 392.2KPLN 392,218 |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Public sector contracts
Euro-Apteka is the contractor in 3 public sector contracts, worth PLN 1.01k in total. They were signed with 3 public buyers.
| Public buyer | Value | |
|---|---|---|
| Państwowe Liceum Sztuk Plastycznych Im. Magdaleny Abakanowicz w Gdyni | PLN 76.33 | |
| SĄD Rejonowy w Siemianowicach Śląskich | PLN 34.78 | |
| Uniwersytet Mikołaja Kopernika w Toruniu | PLN 900.00 |
National Health Fund (NFZ) contracts
Euro-Apteka has been an NFZ healthcare provider since 2015. In 2026 it is performing 25 contracts with a total value of USD 3.08k. All its contracts were worth USD 26.21k in total.
NFZ contract value by year (in k USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Programy pilotażowe | małopolskie | 1 | USD 945.43 |
| Programy pilotażowe | zachodniopomorskie | 3 | USD 702.32 |
| Programy pilotażowe | mazowieckie | 2 | USD 553.75 |
| Programy pilotażowe | wielkopolskie | 2 | USD 391.68 |
| Programy pilotażowe | dolnośląskie | 1 | USD 324.15 |
Trademarks
Euro-Apteka currently holds no active trademarks with the Polish Patent Office. 5 marks have expired or were not registered. The first mark was filed in 2001.
| Mark | Protected until | |
|---|---|---|
| EURO GROSIK 1 GROSZ | – | |
| EURO APTEKA KAŻDY MA PRAWO DO TANICH LEKÓW | – | |
| EURO APTEKA "CENTRUM FARMACEUTYCZNE" | – | |
| EURO APTEKA "CENTRUM FARMACEUTYCZNE" | – | |
| EURO APTEKA | – |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Manner of representation
The management board consists of at least two members of the management board. If a multi-member management board is appointed, two members of the management board acting jointly, or one member of the management board acting together with a commercial proxy, are authorised to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Doz S.A. | 184,500 | $4,983,792.54 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Apteka Polonezsp. z o.o. | 837,385.20 USD | 100% | ||
Savimasp. z o.o. | 59,427.34 USD | 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Cosmedicasp. z o.o. | $49,355,260.75 | cosmedica.pl | ||
| DR ZdrowieS.A. | $40,415,498.47 | drzdrowie.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| MaglowS.A. | $1,356,219.12 | maglow.pl | ||
| Farmacja Im. O. Klimuszkisp. z o.o. | $1,289,548.20 | zyj-zdrowo.com | ||
| Nukloversp. z o.o. | $227,479.26 | nuklover.com | ||
| Massmedsp. z o.o. | $49,747.70 | mojoapps.co | ||
| DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A. | $2,740.83 | kwendasa.pl | ||
| Femaherbsp. z o.o. | $655.76 | femaherb.com |
Change history
| Date | Event | |
|---|---|---|
| 2021-12-09 | Address change (Żytnia 15/14, 01-014, Warszawa → Aleje Jerozolimskie 134, 02-305, Warszawa) | |
| 2021-07-29 | Share capital change (18,350,000.00 PLN → 18,450,000.00 PLN) | |
| 2020-04-14 | Share capital change (18,250,000.00 PLN → 18,350,000.00 PLN) | |
| 2019-03-15 | Share capital change (18,150,000.00 PLN → 18,250,000.00 PLN) | |
| 2019-02-22 | Share capital change (16,000,000.00 PLN → 18,150,000.00 PLN) |
FAQ
Last updated: 2026-10-07